Liver-specific adiponectin gene therapy suppresses microglial NLRP3-inflammasome activation for treating Alzheimer’s diseaseRoy Chun-Laam Ng(University of Hong Kong), Koon‐Ho Chan(University of Hong Kong)Journal of NeuroinflammationMarch 27, 202410.1186/s12974-024-03066-yCited by 23SaveCiteExport RISWatch citationsRelated PapersChronic adiponectin deficiency leads to Alzheimer’s disease-like cognitive impairments and pathologies through AMPK inactivation and cerebral insulin resistance in aged mice|Molecular Neurodegeneration|2016|186Adiponectin is Protective against Oxidative Stress Induced Cytotoxicity in Amyloid-Beta Neurotoxicity|PLoS ONE|2012|145